The conformational dynamics of Hepatitis C Virus E2 glycoprotein with the increasing number of N-glycosylation unraveled by molecular dynamics simulations

References

• Alibay, I., & Bryce, R. A. (2019). Ring puckering landscapes of glycosaminoglycan-related monosaccharides from molecular dynamics simulations. Journal of Chemical Information and Modeling, 59(11), 4729–4741. https://doi.org/10.1021/acs.jcim.9b00529
   PubMed Web of Science ®Google Scholar
• Ardá, A., & Jiménez-Barbero, J. (2018). The recognition of glycans by protein receptors. Insights from NMR spectroscopy. Chemical Communications (Cambridge, England), 54(38), 4761–4769. https://doi.org/10.1039/c8cc01444b
   PubMed Web of Science ®Google Scholar
• Augestad, E. H., Castelli, M., Clementi, N., Ströh, L. J., Krey, T., Burioni, R., Mancini, N., Bukh, J., & Prentoe, J. (2020). Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity. Science Advances, 6(35), eabb5938. https://doi.org/10.1126/sciadv.abb5938
   PubMed Web of Science ®Google Scholar
• Bao, H., He, W., & Chen, J. (2023). Exploring conformation changes of Janus kinase 2 pseudokinase mediated by mutations through Gaussian accelerated molecular dynamics and principal component analysis. Journal of Biomolecular Structure & Dynamics, 1–18. https://doi.org/10.1080/07391102.2023.2260486
   Web of Science ®Google Scholar
• Barman, B., Bora, K., Lynrah, K. G., Lyngdoh, W. V., & Jamil, M. (2018). Hepatitis C virus and its genotypes in chronic liver disease patients from Meghalaya, Northeast India. Indian Journal of Medical Microbiology, 36(3), 376–380. https://doi.org/10.4103/ijmm.IJMM_17_371
   PubMed Web of Science ®Google Scholar
• Barone, D., Balasco, N., Autiero, I., & Vitagliano, L. (2017). The dynamic properties of the Hepatitis C Virus E2 envelope protein unraveled by molecular dynamics. Journal of Biomolecular Structure & Dynamics, 35(4), 805–816. https://doi.org/10.1080/07391102.2016.1162198
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J., Postma, J. V., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Blackard, J. T., Shata, M. T., Shire, N. J., & Sherman, K. E. (2008). Acute hepatitis C virus infection: A chronic problem. Hepatology (Baltimore, Md.), 47(1), 321–331. https://doi.org/10.1002/hep.21902
   PubMed Web of Science ®Google Scholar
• Brazzoli, M., Bianchi, A., Filippini, S., Weiner, A., Zhu, Q., Pizza, M., & Crotta, S. (2008). CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. Journal of Virology, 82(17), 8316–8329. https://doi.org/10.1128/JVI.00665-08
   PubMed Web of Science ®Google Scholar
• Castelli, M., Clementi, N., Pfaff, J., Sautto, G. A., Diotti, R. A., Burioni, R., Doranz, B. J., Dal Peraro, M., Clementi, M., & Mancini, N. (2017). A biologically-validated HCV E1E2 heterodimer structural model. Scientific Reports, 7(1), 214. https://doi.org/10.1038/s41598-017-00320-7
   PubMedGoogle Scholar
• Chen, J., Wang, W., Sun, H., Pang, L., & Bao, H. (2021). Binding mechanism of inhibitors to p38α MAP kinase deciphered by using multiple replica Gaussian accelerated molecular dynamics and calculations of binding free energies. Computers in Biology and Medicine, 134, 104485. https://doi.org/10.1016/j.compbiomed.2021.104485
   PubMed Web of Science ®Google Scholar
• Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (New York, N.Y.), 244(4902), 359–362. https://doi.org/10.1126/science.2523562
   PubMed Web of Science ®Google Scholar
• Cormier, E. G., Tsamis, F., Kajumo, F., Durso, R. J., Gardner, J. P., & Dragic, T. (2004). CD81 is an entry coreceptor for hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America, 101(19), 7270–7274. https://doi.org/10.1073/pnas.0402253101
   PubMed Web of Science ®Google Scholar
• D. A., Case, I. Y. B.-S S. R., Brozell, D. S., Cerutti, T. E., Cheatham, III, V. W. D., Cruzeiro, T. A., Darden, R. E., Duke, D. G. M. K., Gilson, H., Gohlke, A. W., Goetz, D., Greene, R., Harris, N., Homeyer, Y., Huang, S., Izadi, A. K. T., Kurtzman, T. S., Lee, S., LeGrand, P., Li, C., Lin, J., Liu, T., Luchko, R., Luo, D. J., Mermelstein, K. M. M., Y., Miao, G., Monard, C., Nguyen, H., Nguyen, I., Omelyan, A., Onufriev, F., Pan, R., Qi, D. R. R., A., Roitberg, C., Sagui, S., Schott-Verdugo, J., Shen, C. L., Simmerling, J., Smith, R., SalomonFerrer, J., Swails, R. C., Walker, J., Wang, H., Wei, R. M., Wolf, X., Wu, … L., Xiao, D. M., York, P. A., Kollman. (2018). AMBER, 2018.
   Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Dauchez, M., Mazurier, J., Montreuil, J., Spik, G., & Vergoten, G. (1992). Molecular dynamics simulations of a monofucosylated biantennary glycan of the N-acetyllactosamine type: The human lactotransferrin glycan. Biochimie, 74(1), 63–74. https://doi.org/10.1016/0300-9084(92)90185-h
   PubMed Web of Science ®Google Scholar
• Dobrica, M.-O., van Eerde, A., Tucureanu, C., Onu, A., Paruch, L., Caras, I., Vlase, E., Steen, H., Haugslien, S., Alonzi, D., Zitzmann, N., Bock, R., Dubuisson, J., Popescu, C.-I., Stavaru, C., Liu Clarke, J., & Branza-Nichita, N. (2021). Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus‐neutralizing activity in vaccinated mice. Plant Biotechnology Journal, 19(10), 2027–2039. https://doi.org/10.1111/pbi.13631
   PubMed Web of Science ®Google Scholar
• Dong, C., Lee, J., Kim, S., Lai, W., Webb, E. B., Oztekin, A., Zhang, X. F., & Im, W. (2018). Long-ranged protein-glycan interactions stabilize Von Willebrand factor A2 domain from mechanical unfolding. Scientific Reports, 8(1), 16017. https://doi.org/10.1038/s41598-018-34374-y
   PubMedGoogle Scholar
• Douam, F., Dao Thi, V. L., Maurin, G., Fresquet, J., Mompelat, D., Zeisel, M. B., Baumert, T. F., Cosset, F. L., & Lavillette, D. (2014). Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry. Hepatology (Baltimore, Md.), 59(3), 776–788. https://doi.org/10.1002/hep.26733
   PubMed Web of Science ®Google Scholar
• Echeverría, N., Moratorio, G., Cristina, J., & Moreno, P. (2015). Hepatitis C virus genetic variability and evolution. World Journal of Hepatology, 7(6), 831–845. https://doi.org/10.4254/wjh.v7.i6.831
   PubMed Web of Science ®Google Scholar
• El-Bastawissy, E., & Elhasab, M. (2015). Molecular docking and molecular dynamic simulation: Insight into the difference in binding of HCV NS3/4A macrocclic inhibitors to genotypes 1b and 4a. Drug Designing: Open Access, 04(02), 2169. https://doi.org/10.4172/2169-0138.1000124
   Google Scholar
• Farquhar, M., & McKeating, J. A. (2008). Primary hepatocytes as targets for hepatitis C virus replication. Journal of Viral Hepatitis, 15(12), 849–854. https://doi.org/10.1111/j.1365-2893.2008.01051.x
   PubMed Web of Science ®Google Scholar
• Fiser, A., Do, R. K., & Sali, A. (2000). Modeling of loops in protein structures. Protein Science: A Publication of the Protein Society, 9(9), 1753–1773. https://doi.org/10.1110/ps.9.9.1753
   PubMed Web of Science ®Google Scholar
• Flyak, A. I., Ruiz, S., Colbert, M. D., Luong, T., Crowe, J. E., Jr, Bailey, J. R., & Bjorkman, P. J. (2018). HCV broadly neutralizing antibodies use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design. Cell Host & Microbe, 24(5), 703–716. e703. https://doi.org/10.1016/j.chom.2018.10.009
   PubMed Web of Science ®Google Scholar
• Flyak, A. I., Ruiz, S. E., Salas, J., Rho, S., Bailey, J. R., & Bjorkman, P. J. (2020). An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein. eLife, 9, e53169. https://doi.org/10.7554/eLife.53169
   PubMed Web of Science ®Google Scholar
• Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991). The energy landscapes and motions of proteins. Science (New York, N.Y.), 254(5038), 1598–1603. https://doi.org/10.1126/science.1749933
   PubMed Web of Science ®Google Scholar
• Goffard, A., Callens, N., Bartosch, B., Wychowski, C., Cosset, F.-L., Montpellier, C., & Dubuisson, J. (2005). Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. Journal of Virology, 79(13), 8400–8409. https://doi.org/10.1128/JVI.79.13.8400-8409.2005
   PubMed Web of Science ®Google Scholar
• Gopal, R., Jackson, K., Tzarum, N., Kong, L., Ettenger, A., Guest, J., Pfaff, J. M., Barnes, T., Honda, A., Giang, E., Davidson, E., Wilson, I. A., Doranz, B. J., & Law, M. (2017). Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis. PLoS Pathogens, 13(12), e1006735. https://doi.org/10.1371/journal.ppat.1006735
   PubMed Web of Science ®Google Scholar
• Guest, J. D., & Pierce, B. G. (2018). Computational modeling of hepatitis C virus envelope glycoprotein structure and recognition. Frontiers in Immunology, 9, 1117. https://doi.org/10.3389/fimmu.2018.01117
   PubMed Web of Science ®Google Scholar
• Hao, D., Yang, Z., Gao, T., Tian, Z., Zhang, L., & Zhang, S. (2018). Role of glycans in cholesteryl ester transfer protein revealed by molecular dynamics simulation. Proteins, 86(8), 882–891. https://doi.org/10.1002/prot.25520
   PubMed Web of Science ®Google Scholar
• He, L., Cheng, Y., Kong, L., Azadnia, P., Giang, E., Kim, J., Wood, M. R., Wilson, I. A., Law, M., & Zhu, J. (2015). Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding. Scientific Reports, 5(1), 12501. https://doi.org/10.1038/srep12501
   PubMedGoogle Scholar
• Hebert, D. N., Zhang, J.-X., Chen, W., Foellmer, B., & Helenius, A. (1997). The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. The Journal of Cell Biology, 139(3), 613–623. https://doi.org/10.1083/jcb.139.3.613
   PubMed Web of Science ®Google Scholar
• Helle, F., Duverlie, G., & Dubuisson, J. (2011). The hepatitis C virus glycan shield and evasion of the humoral immune response. Viruses, 3(10), 1909–1932. https://doi.org/10.3390/v3101909
   PubMed Web of Science ®Google Scholar
• Helle, F., Vieyres, G., Elkrief, L., Popescu, C.-I., Wychowski, C., Descamps, V., Castelain, S., Roingeard, P., Duverlie, G., & Dubuisson, J. (2010). Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. Journal of Virology, 84(22), 11905–11915. https://doi.org/10.1128/JVI.01548-10
   PubMed Web of Science ®Google Scholar
• Ichiye, T., & Karplus, M. (1991). Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins, 11(3), 205–217. https://doi.org/10.1002/prot.340110305
   PubMed Web of Science ®Google Scholar
• Jeffrey, G. A., & Jeffrey, G. A. (1997). An introduction to hydrogen bonding (Vol. 12). Oxford University Press.
   Google Scholar
• Jo, S., Qi, Y., & Im, W. (2016). Preferred conformations of N-glycan core pentasaccharide in solution and in glycoproteins. Glycobiology, 26(1), 19–29. https://doi.org/10.1093/glycob/cwv083
   PubMed Web of Science ®Google Scholar
• Keck, Z-y., Xia, J., Wang, Y., Wang, W., Krey, T., Prentoe, J., Carlsen, T., Li, A. Y.-J., Patel, A. H., Lemon, S. M., Bukh, J., Rey, F. A., & Foung, S. K. H. (2012). Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathogens, 8(4), e1002653. https://doi.org/10.1371/journal.ppat.1002653
   PubMed Web of Science ®Google Scholar
• Kirschner, K. N., Yongye, A. B., Tschampel, S. M., González‐Outeiriño, J., Daniels, C. R., Foley, B. L., & Woods, R. J. (2008). GLYCAM06: A generalizable biomolecular force field. Carbohydrates. Journal of Computational Chemistry, 29(4), 622–655. https://doi.org/10.1002/jcc.20820
   PubMed Web of Science ®Google Scholar
• Kräutler, V., van Gunsteren, W. F., & Hünenberger, P. H. (2001). A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. Journal of Computational Chemistry, 22(5), 501–508. https://doi.org/10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V
   Web of Science ®Google Scholar
• Kumar, A., Rohe, T. C., Elrod, E. J., Khan, A. G., Dearborn, A. D., Kissinger, R., Grakoui, A., & Marcotrigiano, J. (2023). Regions of hepatitis C virus E2 required for membrane association. Nature Communications, 14(1), 433. https://doi.org/10.1038/s41467-023-36183-y
   PubMed Web of Science ®Google Scholar
• Lavie, M., Goffard, A., & Dubuisson, J. (2006). HCV glycoproteins: Assembly of a functional E1–E2 Heterodimer (Hepatitis C viruses: Genomes and molecular biology. Horizon Bioscience.
   Google Scholar
• Lavie, M., Hanoulle, X., & Dubuisson, J. (2018). Glycan shielding and modulation of hepatitis C virus neutralizing antibodies. Frontiers in Immunology, 9, 910. https://doi.org/10.3389/fimmu.2018.00910
   PubMed Web of Science ®Google Scholar
• Lee, H. S., Qi, Y., & Im, W. (2015). Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study. Scientific Reports, 5(1), 8926. https://doi.org/10.1038/srep08926
   PubMedGoogle Scholar
• Liang, T. J., Feld, J. J., Cox, A. L., & Rice, C. M. (2021). Controlled human infection model-fast track to HCV vaccine? The New England Journal of Medicine, 385(13), 1235–1240. https://doi.org/10.1056/NEJMsb2109093
   PubMed Web of Science ®Google Scholar
• Lindenbach, B. D., & Rice, C. M. (2005). Unravelling hepatitis C virus replication from genome to function. Nature, 436(7053), 933–938. https://doi.org/10.1038/nature04077
   PubMed Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Marín, M. Q., Sliepen, K., García-Arriaza, J., Koekkoek, S. M., Pérez, P., Sorzano, C. Ó. S., Gómez, C. E., Sanders, R. W., & Esteban, M. (2020). Optimized hepatitis C virus (HCV) E2 glycoproteins and their immunogenicity in combination with MVA-HCV. Vaccines, 8(3), 440. https://doi.org/10.3390/vaccines8030440
   Web of Science ®Google Scholar
• Mellquist, J., Kasturi, L., Spitalnik, S., & Shakin-Eshleman, S. (1998). The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry, 37(19), 6833–6837. https://doi.org/10.1021/bi972217k
   PubMed Web of Science ®Google Scholar
• Metcalf, M. C., Janus, B. M., Yin, R., Wang, R., Guest, J. D., Pozharski, E., Law, M., Mariuzza, R. A., Toth, E. A., Pierce, B. G., Fuerst, T. R., & Ofek, G. (2023). Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies. Nature Communications, 14(1), 3980. https://doi.org/10.1038/s41467-023-39659-z
   PubMed Web of Science ®Google Scholar
• Mitra, N., Sharon, N., & Surolia, A. (2003). Role of N-linked glycan in the unfolding pathway of Erythrina corallodendron lectin. Biochemistry, 42(42), 12208–12216. https://doi.org/10.1021/bi035169e
   PubMed Web of Science ®Google Scholar
• Nagae, M., & Yamaguchi, Y. (2012). Function and 3D structure of the N-glycans on glycoproteins. International Journal of Molecular Sciences, 13(7), 8398–8429. https://doi.org/10.3390/ijms13078398
   PubMed Web of Science ®Google Scholar
• Nagalakshmamma, V., Venkataswamy, M., Pasala, C., Umamaheswari, A., Thyagaraju, K., Nagaraju, C., & Chalapathi, P. V. (2020). Design, synthesis, anti-tobacco mosaic viral and molecule docking simulations of urea/thiourea derivatives of 2-(piperazine-1-yl)-pyrimidine and 1-(4-Fluoro/4-Chloro phenyl)-piperazine and 1-(4-Chloro phenyl)-piperazine–A study. Bioorganic Chemistry, 102, 104084. https://doi.org/10.1016/j.bioorg.2020.104084
   PubMed Web of Science ®Google Scholar
• Ohuchi, M., Ohuchi, R., Feldmann, A., & Klenk, H.-D. (1997). Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. Journal of Virology, 71(11), 8377–8384. https://doi.org/10.1128/JVI.71.11.8377-8384.1997
   PubMed Web of Science ®Google Scholar
• Organization, W. H. (2017). Global hepatitis report 2017. World Health Organization.
   Google Scholar
• Pasala, C., Katari, S. K., Nalamolu, R. M., Bitla, A. R., & Amineni, U. (2019). Hierarchical-clustering, scaffold-mining exercises and dynamics simulations for effectual inhibitors against lipid-A biosynthesis of Helicobacter pylori. Cellular and Molecular Bioengineering, 12(3), 255–274. https://doi.org/10.1007/s12195-019-00572-5
   PubMed Web of Science ®Google Scholar
• Pastor, R. W., Brooks, B. R., & Szabo, A. (1988). An analysis of the accuracy of Langevin and molecular dynamics algorithms. Molecular Physics, 65(6), 1409–1419. https://doi.org/10.1080/00268978800101881
   Web of Science ®Google Scholar
• Pérez, S., & de Sanctis, D. (2017). Glycoscience@ Synchrotron: Synchrotron radiation applied to structural glycoscience. Beilstein Journal of Organic Chemistry, 13(1), 1145–1167. https://doi.org/10.3762/bjoc.13.114
   PubMedGoogle Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., & Abrignani, S. (1998). Binding of hepatitis C virus to CD81. Science (New York, N.Y.), 282(5390), 938–941. https://doi.org/10.1126/science.282.5390.938
   PubMed Web of Science ®Google Scholar
• Price, D. J., & Brooks, C. L. III, (2004). A modified TIP3P water potential for simulation with Ewald summation. The Journal of Chemical Physics, 121(20), 10096–10103. https://doi.org/10.1063/1.1808117
   PubMed Web of Science ®Google Scholar
• Qi, Y., Jo, S., & Im, W. (2016). Roles of glycans in interactions between gp120 and HIV broadly neutralizing antibodies. Glycobiology, 26(3), 251–260.
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. III, (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Roy, R., Ghosh, B., & Kar, P. (2020). Investigating conformational dynamics of Lewis Y Oligosaccharides and elucidating blood group dependency of cholera using molecular dynamics. ACS Omega, 5(8), 3932–3942. https://doi.org/10.1021/acsomega.9b03398
   PubMed Web of Science ®Google Scholar
• Saeed, U., Waheed, Y., & Ashraf, M. (2014). Hepatitis B and hepatitis C viruses: A review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology. Asian Pacific Journal of Tropical Disease, 4(2), 88–96. https://doi.org/10.1016/S2222-1808(14)60322-4
   Google Scholar
• Salas, J. H., Urbanowicz, R. A., Guest, J. D., Frumento, N., Figueroa, A., Clark, K. E., Keck, Z., Cowton, V. M., Cole, S. J., Patel, A. H., Fuerst, T. R., Drummer, H. E., Major, M., Tarr, A. W., Ball, J. K., Law, M., Pierce, B. G., Foung, S. K. H., & Bailey, J. R. (2022). An antigenically diverse, representative panel of envelope glycoproteins for hepatitis C virus vaccine development. Gastroenterology, 162(2), 562–574. https://doi.org/10.1053/j.gastro.2021.10.005
   PubMed Web of Science ®Google Scholar
• Sandomenico, A., Leonardi, A., Berisio, R., Sanguigno, L., Focà, G., Focà, A., Ruggiero, A., Doti, N., Muscariello, L., Barone, D., Farina, C., Owsianka, A., Vitagliano, L., Patel, A. H., & Ruvo, M. (2016). Generation and characterization of monoclonal antibodies against a cyclic variant of hepatitis C virus E2 epitope 412–422. Journal of Virology, 90(7), 3745–3759. https://doi.org/10.1128/JVI.02397-15
   PubMed Web of Science ®Google Scholar
• Ströh, L. J., & Krey, T. (2020). HCV glycoprotein structure and implications for B-cell vaccine development. International Journal of Molecular Sciences, 21(18), 6781. https://doi.org/10.3390/ijms21186781
   PubMed Web of Science ®Google Scholar
• Tong, Y., Lavillette, D., Li, Q., & Zhong, J. (2018). Role of hepatitis C virus envelope glycoprotein E1 in virus entry and assembly. Frontiers in Immunology, 9, 1411. https://doi.org/10.3389/fimmu.2018.01411
   PubMed Web of Science ®Google Scholar
• Toth, E. A., Andrianov, A. K., & Fuerst, T. R. (2023). Prospects for developing an Hepatitis C virus E1E2‐based nanoparticle vaccine. Reviews in Medical Virology, 33(5), e2474. https://doi.org/10.1002/rmv.2474
   PubMed Web of Science ®Google Scholar
• Tzarum, N., Giang, E., Kadam, R. U., Chen, F., Nagy, K., Augestad, E. H., Velázquez-Moctezuma, R., Keck, Z.-Y., Hua, Y., Stanfield, R. L., Dreux, M., Prentoe, J., Foung, S. K. H., Bukh, J., Wilson, I. A., & Law, M. (2020). An alternate conformation of HCV E2 neutralizing face as an additional vaccine target. Science Advances, 6(30), eabb5642. https://doi.org/10.1126/sciadv.abb5642
   PubMed Web of Science ®Google Scholar
• Urbanowicz, R. A., Wang, R., Schiel, J. E., Keck, Z.-Y., Kerzic, M. C., Lau, P., Rangarajan, S., Garagusi, K. J., Tan, L., Guest, J. D., Ball, J. K., Pierce, B. G., Mariuzza, R. A., Foung, S. K. H., & Fuerst, T. R. (2019). Antigenicity and immunogenicity of differentially glycosylated hepatitis C virus E2 envelope proteins expressed in mammalian and insect cells. Journal of Virology, 93(7), e01403-18. https://doi.org/10.1128/JVI.01403-18
   PubMed Web of Science ®Google Scholar
• Von Messling, V., & Cattaneo, R. (2003). N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. Journal of Virology, 77(19), 10202–10212. https://doi.org/10.1128/jvi.77.19.10202-10212.2003
   PubMed Web of Science ®Google Scholar
• Wang, S.-H., Wu, T.-J., Lee, C.-W., & Yu, J. (2020). Dissecting the conformation of glycans and their interactions with proteins. Journal of Biomedical Science, 27(1), 93. https://doi.org/10.1186/s12929-020-00684-5
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2016). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 54(1), 5.6. 1–5.6. 37. https://doi.org/10.1002/cpbi.3
   PubMedGoogle Scholar
• Wormald, M. R., Petrescu, A. J., Pao, Y.-L., Glithero, A., Elliott, T., & Dwek, R. A. (2002). Conformational studies of oligosaccharides and glycopeptides: Complementarity of NMR, X-ray crystallography, and molecular modelling. Chemical Reviews, 102(2), 371–386. https://doi.org/10.1021/cr990368i
   PubMed Web of Science ®Google Scholar
• Zaltron, S., Spinetti, A., Biasi, L., Baiguera, C., & Castelli, F. (2012). Chronic HCV infection: Epidemiological and clinical relevance. BMC Infectious Diseases, 12 Suppl 2(Suppl 2), S2. https://doi.org/10.1186/1471-2334-12-S2-S2
   PubMedGoogle Scholar
• Zeisel, M. B., Fofana, I., Fafi-Kremer, S., & Baumert, T. F. (2011). Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies. Journal of Hepatology, 54(3), 566–576. https://doi.org/10.1016/j.jhep.2010.10.014
   PubMed Web of Science ®Google Scholar
• Zhang, H., Bull, R. A., Quadeer, A. A., & McKay, M. R. (2023). HCV E1 influences the fitness landscape of E2 and may enhance escape from E2-specific antibodies. Virus Evolution, 9(2), vead068. https://doi.org/10.1093/ve/vead068
   PubMed Web of Science ®Google Scholar
• Zhang, J., Randall, G., Higginbottom, A., Monk, P., Rice, C. M., & McKeating, J. A. (2004). CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. Journal of Virology, 78(3), 1448–1455. https://doi.org/10.1128/jvi.78.3.1448-1455.2004
   PubMed Web of Science ®Google Scholar